Sagar U Nigwekar
Overview
Explore the profile of Sagar U Nigwekar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
2259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dember L, Hsu J, Mehrotra R, Cavanaugh K, Kalim S, Charytan D, et al.
JAMA Intern Med
. 2025 Jan;
185(2):197-207.
PMID: 39786400
Importance: Chronic pain is common among individuals with dialysis-dependent kidney failure. Objective: To evaluate the effectiveness of pain coping skills training (PCST), a cognitive behavioral intervention, on pain interference. Design,...
2.
El Mouhayyar C, Chhikara M, Tang M, Nigwekar S
Clin Kidney J
. 2025 Jan;
18(1):sfae346.
PMID: 39781481
The mineralocorticoid receptor (MR) is a nuclear transcription factor that plays a critical role in regulating fluid, electrolytes, blood pressure, and hemodynamic stability. In conditions such as chronic kidney disease...
3.
Nigwekar S, Cima M
Clin J Am Soc Nephrol
. 2024 Dec;
19(12):1518-1520.
PMID: 39652330
No abstract available.
4.
Sinha S, Nigwekar S, Brandenburg V, Gould L, Serena T, Moe S, et al.
EClinicalMedicine
. 2024 Sep;
75:102784.
PMID: 39252867
Background: In the CALCIPHYX trial, we investigated hexasodium fytate, an inhibitor of vascular calcification, for the treatment of calcific uraemic arteriolopathy (calciphylaxis), a rare condition characterised by painful, non-healing skin...
5.
Tan A, Xia J, Glennon C, Locascio J, Gabel C, Nguyen E, et al.
J Am Acad Dermatol
. 2024 Jul;
91(5):834-842.
PMID: 38972479
Background: Calciphylaxis patients historically have experienced diagnostic challenges and high morbidity; however limited data is available examining these characteristics over time. Objective: The primary goals were to a) investigate factors...
6.
Tang M, Berg A, Zheng H, Rhee E, Allegretti A, Nigwekar S, et al.
Am J Kidney Dis
. 2024 Mar;
84(3):329-338.
PMID: 38518919
Rationale & Objective: Hemoglobin A (HbA) is widely used to estimate glycemia, yet it is less reliable in patients with chronic kidney disease (CKD). There is growing interest in the...
7.
Petrosyan R, Endres P, Ufere N, St Hillien S, Krinsky S, Kalim S, et al.
Dig Dis Sci
. 2024 Mar;
69(6):1948-1955.
PMID: 38451428
Background: Patients with cirrhosis and acute kidney injury (AKI) are critically ill and have high health care resource utilization (HCRU). The impact and timing of goals of care discussions on...
8.
Xia J, Tan A, Gabel C, Nguyen E, Chand S, Rrapi R, et al.
J Am Acad Dermatol
. 2024 Feb;
90(6):1287-1289.
PMID: 38382710
No abstract available.
9.
Seethapathy H, Zhao S, Ouyang T, Passos C, Sarang A, Cheung P, et al.
NEJM Evid
. 2024 Feb;
2(10):EVIDoa2300107.
PMID: 38320180
BACKGROUND: In clinical practice, sodium correction rates are frequently limited in patients with severe hyponatremia to prevent neurologic complications. The implications of correction rates on overall mortality and length of...
10.
Nigwekar S, Thakar C
Adv Kidney Dis Health
. 2024 Jan;
31(1):1.
PMID: 38260922
No abstract available.